![]() |
市場調査レポート
商品コード
1670158
医薬品カートリッジの市場規模、シェア、成長分析:材料の種類別、用途別、チャンバータイプ別、サイズ別、治療領域別、最終用途別、地域別 - 産業予測 2025~2032年Pharmaceutical Cartridges Market Size, Share, and Growth Analysis, By Material type, By Application, By Chamber Type, By Size, By Therapeutic Area, By End Use, By Region - Industry Forecast 2025-2032 |
||||||
|
医薬品カートリッジの市場規模、シェア、成長分析:材料の種類別、用途別、チャンバータイプ別、サイズ別、治療領域別、最終用途別、地域別 - 産業予測 2025~2032年 |
出版日: 2025年02月27日
発行: SkyQuest
ページ情報: 英文 166 Pages
納期: 3~5営業日
|
医薬品カートリッジ市場規模は2023年に18億米ドルと評価され、2024年の19億7,000万米ドルから2032年には39億7,000万米ドルに成長し、予測期間(2025~2032年)のCAGRは9.2%で成長する見通しです。
世界の医薬品カートリッジ市場は、糖尿病や関節炎などの慢性疾患の有病率の上昇によりドラッグデリバリーデバイスの需要が高まり、大きな成長を遂げています。WHOの2023年の報告によると、世界で約4億2,200万人が糖尿病に罹患しており、主に中低所得国で年間150万人が死亡しています。この憂慮すべき傾向により、医薬品、特にインスリンやその他の糖尿病治療薬の需要が増加しています。市場動向は、注射器、ペン、吸入器などの先進ドラッグデリバリーシステムへの強いシフトを示しています。これらのデバイスは、ユーザーフレンドリーなデザインと服薬アドヒアランスを向上させる能力で支持されており、プレフィルドカートリッジは正確で安全な医薬品送達を確保するための重要なコンポーネントとして位置づけられています。
Pharmaceutical Cartridges Market size was valued at USD 1.8 billion in 2023 and is poised to grow from USD 1.97 billion in 2024 to USD 3.97 billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).
The global pharmaceutical cartridges market is experiencing significant growth, fueled by the rising prevalence of chronic conditions like diabetes and arthritis, which has heightened demand for drug delivery devices. According to WHO 2023, approximately 422 million people worldwide are affected by diabetes-predominantly in low- and middle-income countries-leading to 1.5 million deaths annually. This alarming trend results in an increased demand for pharmaceuticals, particularly insulin and other diabetes medications. The market trends indicate a strong shift towards advanced drug delivery systems, such as injectors, pens, and inhalers. These devices are favored for their user-friendly designs and ability to enhance medication adherence, positioning prefilled cartridges as a critical component in ensuring precise and safe pharmaceutical delivery.
Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmaceutical Cartridges market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Pharmaceutical Cartridges Market Segments Analysis
Global Pharmaceutical Cartridges Market is segmented by Material type, Application, Chamber Type, Size, Therapeutic Area, End Use and region. Based on Material type, the market is segmented into Glass Cartridges, Plastic Cartridges and Rubber. Based on Application, the market is segmented into Dental Anesthesia, Pen Injectors, Autoinjectors and Wearable Injectors. Based on Chamber Type, the market is segmented into Dual Chamber and Large Volume. Based on Size, the market is segmented into 0.5 ml, 1.8 ml, 2ml to 2.5 ml, 3 ml, 5 ml and More than 10 ml. Based on Therapeutic Area, the market is segmented into Ophthalmology, Respiratory, Neurology, Oncology, Immunology, Cardiology, Diabetes, Dental and Others. Based on End Use, the market is segmented into Pharmaceuticals, Biotechnology, Research Organizations and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Pharmaceutical Cartridges Market
The global pharmaceutical cartridges market is significantly driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders. These health issues often necessitate long-term injection therapies, thereby creating a demand for efficient pharmaceutical cartridge delivery systems. As the rate of these chronic conditions continues to rise, the need for pharmaceutical cartridges will correspondingly increase. Furthermore, the market is expected to see substantial growth in biologics and high-dose injectables, reflecting the ongoing requirement for innovative delivery solutions in managing these long-term health challenges. This trend underscores the critical role pharmaceutical cartridges play in modern healthcare.
Restraints in the Pharmaceutical Cartridges Market
The pharmaceutical cartridges market faces significant restraints due to compatibility issues with modern medication administration systems, such as traditional syringes and autoinjectors. This lack of interoperability can hinder the adoption of these cartridges across various healthcare settings, particularly when different departments use diverse operational systems. Additionally, the complexity and high costs associated with implementing new technologies may further limit the widespread acceptance of innovative cartridge devices. As healthcare providers seek to streamline their practices, these barriers can slow down the integration of advanced solutions, ultimately impacting the growth and development of the pharmaceutical cartridges market.
Market Trends of the Pharmaceutical Cartridges Market
The pharmaceutical cartridges market is experiencing a notable upward trend, fueled by the rising demand for pre-filled syringes and cartridges, which offer enhanced precision, usability, and reduced risk of exposure. This increase is driven primarily by the need for accurate dosage and compliance in the administration of injectable medications, biological products, and vaccines, necessitating reliable delivery systems. The convenience of self-management therapies for chronic illnesses, combined with the ready-to-use nature of these products, is further propelling market growth. As healthcare systems adapt to patient-centric care models, the integration of such advanced delivery systems is revolutionizing medication administration, ensuring better outcomes and adherence.